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ABSTRAK 
 
Ini adalah satu kajian retrospektif untuk melihat presentasi kanser payudara dan cara 
ianya dikesan dikalangan pesakit di Hospital Kuala Lumpur. Sebanyak 366 rekod pesakit 
dari Klinik Endokrin dan Payudara dianalisa. Hasil kajian menunjukan kebanyakan pesakit 
adalah dalam lingkungan umur 40-49 tahun (39.6%). Sebanyak 81.4% pesakit 
menunjukkan ketulan pada payudara dan mengesan ketulan ini sendiri (97.3%). Diameter 
min tumor semasa presentasi adalah 4.7± 3 cm. Sebanyak 1.6% penyakit di kesan oleh 
kakitangan perubatan dan 1.1% lagi dikesan melalui mamogram. Kesimpulannya, 
kebanyakan pesakit mengesan ketulan pada payudara mereka sendiri. Ini mencadangkan 
bahawa kaedah pemeriksaan sendiri payudara boleh digunakan sebagai saringan untuk 
mengesan tanda-tanda awal kanser payudara, sekiranya kemudahan mamogram tidak 
ada. Pengesanan awal melalui pemeriksaan sendiri dapat menawarkan pilihan rawatan 
dan kualiti hidup yang lebih baik sungguhpun terdapat bukti yang menyatakan bahawa 
kaedah ini tidak dapat mengurangkan mortaliti kanser payudara. 
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ABSTRACT 
 
This is a retrospective descriptive study done to look at common presentation and method 
of detection of breast cancer. A total of 366 case records of patients attending the Breast 
and Endocrine Clinic at Hospital Kuala Lumpur were reviewed. The peak age of breast 
cancer presentation was 40 to 49 years (39.6%). Most (81.4%) patients presented with a 
lump in the breast and the lump was mainly self-detected (97.3%). The mean tumour 
diameter on presentation was 4.7± 3 cm. Medical staff detected the disease in 1.6% cases 
and 1.1% of cases were detected by mammogram. Most women detected the lump 
themselves, suggesting that Breast Self Examination (BSE) can be used for detection of 
the disease in places where there is cost and availability constrains for mammogram. Early 
detection with BSE can possibly offer better treatment options and quality of life despite the 
evidence that it does not reduce the mortality due to breast cancer. 
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INTRODUCTION 
 
Breast cancer is the commonest cancer 
among females in most parts of the world, 
with an increasing incidence in developing 
countries (GLOBOCCAN 2000). In Malay-
sia, it accounts for 30.4% of newly diag-
nosed cancer and it is the commonest 
cancer in females of all ethnic groups (The 
National Cancer Registry 2002). The 
Ministry of Health (MOH) Malaysia, has 
advocated the practice of Breast Self 
Examination (BSE) as a screening tool for 
breast cancer since 1996. The Malaysian 
Clinical Practice Guidelines on manage-
ment of breast cancer 2002,  formulated by 
the Academy of Medicine and the Ministry 
of Health, is also in favour of monthly BSE 
for women aged 20 and above.  
In the West however, the trend is 
moving away from BSE as there are 
controversies with regard to its practice. 
The Canadian Task Force on Preventive 
Health Care (CTFPHC) and the United 
States Preventive Services Task Force 
(USPSTF) states that there is insufficient 
evidence of benefit for or against BSE 
based on the review of a number of 
studies. One large trial, The Shanghai Trial 
(Harris and Kinsinger 2002), claims that 
there is no evidence of reduction in 
mortality by performing BSE. The National 
Guideline Clearinghouse (NGC 2004) 
states that BSE causes undue anxiety, and 
increase in the number of physician visits 
for evaluation of benign breast biopsies in 
those who were taught BSE. The objective 
of this study is to determine how breast 
cancer was detected in a referral center, 
and how this information, along with the 
recent controversies, be used to justify the 
practice of BSE in our local setting. 
 
MATERIALS AND METHODS 
 
Case notes of patients diagnosed with 
breast cancer from January 1996 to 
December 1997 were reviewed. All Malay-
sian female patients were included. Those 
with missing files were excluded. Case 
notes were reviewed manually and entered 
into a pre-coded data collection form. 
Breast cancer presentation was divided 
into those with lump, skin manifestations 
(retracted nipple, peau d’orange or ulcers) 
and those without any symptoms. The 
detection of the changes was categorised 
into those detected by the patients, medical 
personnel and mammogram. The average 
tumor diameter was recorded as docu-
mented in the patient’s file. The results 
were analysed using the Statistical Pack-
age for Social Sciences (SPSS) software 
version 11.5. 
 
RESULTS 
 
A total of 394 case notes were reviewed of 
which 366 were selected. Twenty-eight 
were excluded including 18 whose files 
were missing, five cases were foreigners, 
four had incomplete socio-demographic 
information, and one was a male patient.  
The age group most commonly affected 
were those between 40 to 49 years 
(39.6%) with a mean of 48.6 ± 11.8 years. 
The vast majority (97.3%) of these patients 
detected the disease themselves. Medical 
staff detected 1.6% cases and 1.1% cases 
were detected by mammogram. The 
commonest mode of presentation is a 
breast lump (81.4%) followed by skin 
changes over the breast (17.5%). The 
mean tumour diameter on presentation 
was 4.7± 3 cm.  
 
DISCUSSION 
 
The peak age group for breast cancer 
presentation is similar to the study done by 
Yip and Ng 1996 and Hisham and Yip 
2003. The common presenting symptom is 
a breast lump (81.4%), and most patients 
detected it themselves (97.3%). This is in 
contrast to an American study (Osteen et al 
1994) where the number of women who 
presented with a breast lump was 42.2% 
and the rate of detection of the lump by the 
patients themselves was 43.9%. Although 
this figure appears lower, it must be 
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emphasised that more than half of the 
lumps in that study were detected by 
screening mammogram; 56.1% compared 
to 1.1% in this study. This reflects the 
active role of screening mammogram in 
America. Another possible contributing 
factor is that women in this study probably 
detected the lump more easily because it 
was large. More Malaysian women pre-
sented with tumours greater than 2cm 
(77.9%) compared to their counterparts in 
America (37.3%) and Singapore (63%) (Yip 
and Ng 1996). 
 Detection of the disease by mammo-
gram in this study is 1.1%, which is much 
lower compared to the American study 
(Osteen et al. 1994). This is probably 
because the screening program in Malay-
sia recommended by MOH does not in-
clude mammogram as a mass-screening 
tool except in high-risk cases due to limited 
resources. In America, annual mammo-
gram is done for all women 40 years and 
above as recommended by the American 
Joint Committee for Cancer (Leitch et al. 
1997) based on meta-analysis of recent 
trials. 
Although breast cancer was mostly 
detected by patients, it is uncertain whether 
it was detected on routine BSE or was 
merely an incidental finding due to the 
presence of a large lump but this infor-
mation may be used to create awareness 
regarding the disease for early detection. 
There is no conclusive evidence that BSE 
reduces mortality but there are studies 
which have shown that the practice of BSE 
leads to detection of cancer in earlier 
stages and with less lymph node involve-
ment (Huguly and Brown 1981 and Hill et 
al. 1988).  
Detection of disease based on mammo-
graphic screening is very low in this study 
may be due to limited resources or due to 
the fact that it may not be used frequently 
enough as a screening tool to make an 
impact. Primary Care Physicians need to 
carefully select patients for mammogram to 
avoid under or over utilisation. Screening 
mammogram in Malaysia is recommended 
for women of 40 years and above since 
this is the peak age at presentation, 
instead of the current recommendation of 
50 years of age. A large number of cases 
will be missed if screening is done 10 years 
beyond the peak age of presentation. 
Screening mammogram is costly but will 
probably be more economical than bearing 
the management cost of advanced stage 
disease with chemo and radiotherapy.  
There is no doubt that mammogram is a 
sensitive tool (sensitivity & specificity of 95 
- 97%) and can detect lesions of up to 
12mm, (Mushin et al. 1998) but BSE 
practice can be encouraged in countries 
and centres where there is cost and 
availability constrains for a mammogram. 
This can offer better options for treatment 
and a better quality of life if cancer is 
detected at an earlier stage.  
This study, being retrospective, has 
limitations. Incomplete or missing case 
notes could not be analysed. The docu-
mentation of the records was inconsistent, 
hence there was difficulty retrieving the 
relevant data. There may be a selection 
bias, as the sample studied represents the 
population attending a single hospital, 
hence may not give a true reflection of the 
disease presentation in the country. 
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